Kemp Dolliver
Stock Analyst at Brookline Capital
(0.64)
# 4,123
Out of 5,149 analysts
19
Total ratings
38.46%
Success rate
-13.97%
Average return
Main Sectors:
Stocks Rated by Kemp Dolliver
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LSTA Lisata Therapeutics | Downgrades: Hold | n/a | $4.31 | - | 2 | Jan 21, 2026 | |
| RNTX Rein Therapeutics | Downgrades: Hold | n/a | $1.15 | - | 2 | Jan 21, 2026 | |
| VRCA Verrica Pharmaceuticals | Upgrades: Buy | $17 | $5.12 | +232.03% | 3 | Dec 18, 2025 | |
| RADX Radiopharm Theranostics | Initiates: Buy | $18 | $4.87 | +269.99% | 1 | Jul 21, 2025 | |
| IBIO iBio, Inc. | Initiates: Buy | $3.6 | $2.69 | +33.83% | 1 | Jul 22, 2024 | |
| DARE Daré Bioscience | Upgrades: Buy | $36 | $1.57 | +2,200.32% | 2 | May 15, 2024 | |
| OTLK Outlook Therapeutics | Upgrades: Buy | $31 | $0.42 | +7,347.82% | 1 | Jan 25, 2024 | |
| LNTH Lantheus Holdings | Initiates: Buy | $100 | $78.84 | +26.84% | 1 | Nov 30, 2023 | |
| EDSA Edesa Biotech | Maintains: Buy | $57 | $4.35 | +1,210.34% | 2 | Oct 12, 2023 | |
| GNLX Genelux | Initiates: Hold | $25 | $2.58 | +868.99% | 1 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $7.61 | +146.39% | 1 | Jan 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $8 | $0.75 | +964.11% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5.65 | $0.61 | +824.26% | 1 | Feb 2, 2022 |
Lisata Therapeutics
Jan 21, 2026
Downgrades: Hold
Price Target: n/a
Current: $4.31
Upside: -
Rein Therapeutics
Jan 21, 2026
Downgrades: Hold
Price Target: n/a
Current: $1.15
Upside: -
Verrica Pharmaceuticals
Dec 18, 2025
Upgrades: Buy
Price Target: $17
Current: $5.12
Upside: +232.03%
Radiopharm Theranostics
Jul 21, 2025
Initiates: Buy
Price Target: $18
Current: $4.87
Upside: +269.99%
iBio, Inc.
Jul 22, 2024
Initiates: Buy
Price Target: $3.6
Current: $2.69
Upside: +33.83%
Daré Bioscience
May 15, 2024
Upgrades: Buy
Price Target: $36
Current: $1.57
Upside: +2,200.32%
Outlook Therapeutics
Jan 25, 2024
Upgrades: Buy
Price Target: $31
Current: $0.42
Upside: +7,347.82%
Lantheus Holdings
Nov 30, 2023
Initiates: Buy
Price Target: $100
Current: $78.84
Upside: +26.84%
Edesa Biotech
Oct 12, 2023
Maintains: Buy
Price Target: $57
Current: $4.35
Upside: +1,210.34%
Genelux
May 18, 2023
Initiates: Hold
Price Target: $25
Current: $2.58
Upside: +868.99%
Jan 13, 2023
Initiates: Buy
Price Target: $19
Current: $7.61
Upside: +146.39%
Oct 21, 2022
Assumes: Buy
Price Target: $8
Current: $0.75
Upside: +964.11%
Feb 2, 2022
Initiates: Buy
Price Target: $5.65
Current: $0.61
Upside: +824.26%